Yi Zhu

9.6k citations
154 papers · 7.6k indexed · 2 hit papers · h-index 52
Topics
Eicosanoids and Hypertension Pharmacology (36 papers)Cholesterol and Lipid Metabolism (18 papers)Hippo pathway signaling and YAP/TAZ (16 papers)

In The Last Decade

Yi Zhu

149 papers receiving 7.6k citations

Hit Papers

Integrin-YAP/TAZ-JNK cascade mediates atheroprotective ef...201620262019202220162023100200300400

Peers

Yi Zhu
Comparison fields: 5 of 137
  • Molecular Biology 3.4k
  • Biochemistry 1.5k
  • Cell Biology 1.2k
  • Surgery 1.2k
  • Cancer Research 1.1k
Replace Hans‐Peter Hammes with:
Hans‐Peter Hammes Germany
Youfei Guan China
Richard C. Austin Canada
Takanari Gotoda Japan
Timothy E. Peterson United States
Beate Fißlthaler Germany
Gerald Höefler Austria
Wolfgang Siess Germany
Ronald E. Law United States
Seikoh Horiuchi Japan
Yi Zhu relative to Hans‐Peter Hammes Germany Hans‐Peter Hammes's profile →
Citations per field
00.5×3.3×
Hans‐Peter Hammes · 1×
Citations per year

Countries citing papers authored by Yi Zhu

Since Specialization
Citations

This map shows the geographic impact of Yi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhu more than expected).

Fields of papers citing papers by Yi Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhu. The network helps show where Yi Zhu may publish in the future.

Co-authorship network of co-authors of Yi Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhu. A scholar is included among the top collaborators of Yi Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhu. Yi Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 0
4 7
5 3
6 23
7 17
8 32
9 90
10 80
11 93
12 90
13 24
14 14
15 16
16 33
17 8
18 134
19 13
20 7

About Yi Zhu

Yi Zhu is a scholar working on Biochemistry, Immunology and Allergy and Cell Biology, having authored 154 papers that have together received 7.6k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (36 papers), Cholesterol and Lipid Metabolism (18 papers) and Hippo pathway signaling and YAP/TAZ (16 papers). The work is most often cited by research in Biochemistry (1.5k citations), Cancer Research (1.1k citations) and Cell Biology (1.2k citations). Yi Zhu has collaborated with scholars based in China, United States and Romania. Frequent co-authors include Ding Ai, Nanping Wang, Xian Wang, Bruce D. Hammock, Michael B. Stemerman, Tzong‐Shyuan Lee, Xu Zhang, Wei Kong, Jinlong He and Hailing Liao. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026